Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)
China flag China · Delayed Price · Currency is CNY
11.23
+0.03 (0.27%)
Feb 27, 2026, 3:00 PM CST

Tibet Weixinkang Medicine Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4,8554,3304,5396,9284,0513,803
Market Cap Growth
16.10%-4.60%-34.48%71.03%6.52%-15.27%
Enterprise Value
3,8463,2823,7106,1503,4123,260
Last Close Price
11.239.679.6414.478.307.94
PE Ratio
21.6617.5921.2139.1542.2365.09
PS Ratio
4.163.333.434.953.925.31
PB Ratio
3.183.133.395.683.803.87
P/TBV Ratio
3.233.163.485.793.843.94
P/FCF Ratio
39.4913.7626.6541.1235.2047.93
P/OCF Ratio
24.9311.6218.8228.1423.7328.44
EV/Sales Ratio
3.292.522.814.403.304.56
EV/EBITDA Ratio
12.7312.2319.7532.2327.4047.58
EV/EBIT Ratio
15.6014.7825.5839.8036.7287.09
EV/FCF Ratio
31.2910.4321.7936.5129.6441.08
Debt / Equity Ratio
0.010.000.010.010.01-
Debt / EBITDA Ratio
0.030.020.040.030.04-
Debt / FCF Ratio
0.070.020.050.030.04-
Net Debt / Equity Ratio
-0.66-0.73-0.66-0.66-0.66-0.58
Net Debt / EBITDA Ratio
-3.41-3.78-4.72-4.20-5.67-8.40
Net Debt / FCF Ratio
-8.20-3.22-5.21-4.75-6.14-7.25
Asset Turnover
0.610.720.770.890.720.54
Inventory Turnover
11.6815.0518.3724.3422.6721.56
Quick Ratio
3.582.792.732.502.162.18
Current Ratio
4.073.083.042.772.412.43
Return on Equity (ROE)
14.76%18.06%16.71%15.47%9.35%6.11%
Return on Assets (ROA)
8.02%7.64%5.27%6.11%4.07%1.76%
Return on Invested Capital (ROIC)
40.59%47.92%32.94%38.42%20.19%7.77%
Return on Capital Employed (ROCE)
15.60%15.60%10.50%12.30%8.60%3.80%
Earnings Yield
4.57%5.68%4.71%2.55%2.37%1.54%
FCF Yield
2.53%7.27%3.75%2.43%2.84%2.09%
Dividend Yield
2.92%3.54%2.96%1.62%1.93%1.20%
Payout Ratio
71.06%72.25%45.72%38.80%41.90%32.58%
Buyback Yield / Dilution
0.84%-0.90%0.83%-3.50%0.08%2.56%
Total Shareholder Return
3.74%2.64%3.79%-1.88%2.00%3.76%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.